Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1,034 USD | -0.49% | +0.38% | +17.32% |
06-18 | Alvotech Enters Commercialization Deal for Eylea Biosimilars with Advanz Pharma | MT |
06-17 | Regeneron Pharmaceuticals Insider Sold Shares Worth $1,596,400, According to a Recent SEC Filing | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.32% | 112B | |
+14.66% | 121B | |
+4.08% | 22.57B | |
-18.02% | 20.82B | |
-15.01% | 16.3B | |
-16.61% | 16.19B | |
-42.36% | 16.17B | |
+1.62% | 13.17B | |
+23.59% | 11.11B | |
+109.42% | 10.57B |
- Stock Market
- Equities
- REGN Stock
- News Regeneron Pharmaceuticals, Inc.
- Jefferies Raises Regeneron Pharmaceuticals' Price Target to $1,125 From $1,115